This is today’s edition of The Download, our weekday newsletter that provides a daily dose of what’s going on in the world of technology. A startup claims it’s found a drug to make your blood young —Antonio Regalado I knew I’d officially become a “longevity influencer” when a company called Generation Lab offered me the…
Investors, founders, and operators from across Europe arrived for the annual Nordic TechBBQ conference to talk about how humans can have agency over AI.
Vijay Pande — who left a16z’s roughly $4 billion biotech practice last year to start the much smaller, AI-native VZVC — talks about why biology is finally shifting from a “discovery” science to an “engineering” one, why clinical trials are still brutally expensive, and why he thinks open, shared datasets (not walled-off ones) are what will actually let AI transform medicine.
As my 20s are set to come to an end later this year, I’ve officially reached the age where sleeping in the wrong position or stretching just a little too far can cause aches and pains. I’ve always been somewhat skeptical of massage guns, mostly because I’ve tried a few off-brand ones and just assumed […]
Some of the best investment decisions I’ve made never show up anywhere — because the discipline to walk away when everything in the room is leaning forward is what separates real investors from the rest.
In a crowded AI fundraising market, the thing standing between your startup and a term sheet might not be your product. It may be the financial infrastructure behind it.